Westlake Chemical Partners Insider Purchases Increase CEO Holdings to 11,708 Units
Rhea-AI Filing Summary
Westlake Chemical Partners LP (WLKP) insider purchases reported by Jean-Marc Gilson, President and CEO and director. The filing documents multiple open-market acquisitions of common units executed between 11/27/2024 and 08/21/2025, increasing the reporting person’s beneficial ownership from 4,331.96 units to 11,708.195 units. Transaction prices range roughly from $21.81 to $24.75 per unit; some later entries note weighted-average prices from multiple trades. An explanatory note states certain earlier purchases were inadvertently omitted and have been reconciled. No derivative transactions are reported.
Positive
- Significant insider buying: Reporting person increased direct ownership to 11,708.195 common units through multiple open-market purchases.
- Transparent pricing disclosure: Weighted-average price ranges provided for grouped transactions and offer to supply detailed allocations upon request.
- Correction of prior omission: Filing reconciles and reports common units previously not reported.
Negative
- Prior reporting omission: Some common units were inadvertently not reported earlier and required reconciliation.
Insights
TL;DR: CEO/director materially increased holdings via multiple open-market purchases, with reconciled prior omissions.
The filing shows repeated purchases of common units by the reporting person, raising direct beneficial ownership to 11,708.195 units. The purchases span several dates and price ranges, with explanatory notes disclosing weighted-average pricing for batches and a reconciliation entry correcting prior non-reported acquisitions. From a governance standpoint, voluntary insider purchases by a CEO/director typically signal internal confidence in the partnership’s equity, while the reconciliation note highlights a prior reporting omission that was subsequently corrected.
TL;DR: Multiple Form 4 purchases documented; weighted-average pricing disclosed and an inadvertent omission was corrected.
The report records non-derivative acquisitions only, with granular explanatory disclosures on purchase price ranges and an attestation that detailed allocation per price is available if requested. No sales, option exercises, or derivative activity are shown. Compliance-wise, the corrected reporting of previously omitted units is appropriate; the form includes a Power of Attorney signature block indicating authorization for filing.